(GIST OF SCIENCE REPORTER) mRNA CANCER VACCINE

(MARCH-2025)

Russian scientists have developed an mRNA vaccine that has shown the ability to suppress tumour development and metastasis in pre-clinical trials.

The vaccine can be personalised, with genetic mutations being detected in less than an hour using artificial intelligence (AI).

mRNA or messenger RNA vaccines provide genetic information that teaches the body’s cells to produce an antigen (protein or other substance that triggers an immune response), training the immune system to produce antibodies against it.
When these antigens are detected on cancer cells, the immune system can potentially launch an attack against them.

Like all vaccines, mRNA vaccines work by training your body to recognise and create tools to fight something harmful (like a virus).
An mRNA cancer ‘vaccine’ is a form of immunotherapy. The idea of immunotherapy is to boost the body’s immune system to find and destroy cancer cells, preventing their spread.
The advantages of this treatment are that, unlike chemotherapy, only the cancer cells are killed, and the side effects are lowered.
The mRNA cancer vaccines are not meant for healthy patients to prevent disease like other vaccines.
They are meant to be used in patients who already have cancer, in order to target and treat the tumours.
This treatment is tailored to target specific antigens that each patient’s tumour has, making them personalised and potentially more effective.